Europäische Union - Deutsch - EMA (European Medicines Agency)

kyowa kirin holdings b.v. - istradefylline - parkinson krankheit - anti-parkinson-medikamente - istradefylline is indicated in adults as an adjunctive treatment to levodopa based regimens in patients with parkinson’s disease (pd) experiencing “off” time.